Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (4)

Search Parameters:
Authors = Robert M. Otto

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
10 pages, 519 KiB  
Article
The Effect of Post-Exercise Warm Water Immersion on Anaerobic Power Performance in College Students
by Chloe E. Newlands, Michele Aquino, Kevin Z. Young, Soniya T. Gupta, John Petrizzo, John W. Wygand and Robert M. Otto
Physiologia 2024, 4(4), 363-372; https://doi.org/10.3390/physiologia4040022 - 29 Oct 2024
Viewed by 1779
Abstract
Background/Objectives: The purpose of this study was to investigate the effect of a short-term passive post-exercise heat acclimation (HA) protocol on anaerobic performance in college students. Methods: In total, 28 participants (age 22.3 ± 2.1 years, height 168 ± 9.1 cm, mass 71.5 [...] Read more.
Background/Objectives: The purpose of this study was to investigate the effect of a short-term passive post-exercise heat acclimation (HA) protocol on anaerobic performance in college students. Methods: In total, 28 participants (age 22.3 ± 2.1 years, height 168 ± 9.1 cm, mass 71.5 ± 16.6 kg) volunteered and were randomly divided into either an intervention (INT) or control (CON) group. Both groups followed a consecutive two-day protocol, consisting of a 25 min submaximal cycle @ 50–60% heart rate reserve (HRR), followed by a 25 min hot water immersion (INT) or nothing (CON). All participants performed a 30 s Wingate Anaerobic Test (WAnT) on four separate occasions—familiarization, pre-intervention, acutely post-intervention, and 24 h post intervention. The WAnT measured their peak power (W), relative peak power (W/kg), mean power (W), fatigue index (%), and total work (kJ). Results: From the results of the Factorial ANOVA, it was found that there were no significant differences, with no main effect for group (INT vs. CON) or time (Trials 1–4) and no significant interaction across all measured variables (p > 0.05). Conclusions: A two-day post-exercise passive HA protocol utilizing hot water immersion had no significant effect on the measurement of anaerobic performance in college students. Full article
(This article belongs to the Special Issue Exercise Physiology and Biochemistry: 2nd Edition)
Show Figures

Figure 1

13 pages, 712 KiB  
Article
A Phase I Dose Escalation and Expansion Study of Epidiolex (Cannabidiol) in Patients with Biochemically Recurrent Prostate Cancer
by Zin W. Myint, William H. St. Clair, Stephen E. Strup, Donglin Yan, Ning Li, Derek B. Allison, Laurie E. McLouth, Carleton S. Ellis, Peng Wang, Andrew C. James, Patrick J. Hensley, Danielle E. Otto, Susanne M. Arnold, Robert S. DiPaola and Jill M. Kolesar
Cancers 2023, 15(9), 2505; https://doi.org/10.3390/cancers15092505 - 27 Apr 2023
Cited by 6 | Viewed by 3002
Abstract
Purpose: Cannabinoids (CBD) have anti-tumor activity against prostate cancer (PCa). Preclinical studies have demonstrated a significant decrease in prostate specific antigen (PSA) protein expression and reduced tumor growth in xenografts of LNCaP and DU-145 cells in athymic mice when treated with CBD. Over-the-counter [...] Read more.
Purpose: Cannabinoids (CBD) have anti-tumor activity against prostate cancer (PCa). Preclinical studies have demonstrated a significant decrease in prostate specific antigen (PSA) protein expression and reduced tumor growth in xenografts of LNCaP and DU-145 cells in athymic mice when treated with CBD. Over-the-counter CBD products may vary in activity without clear standardization, and Epidiolex is a standardized FDA-approved oral CBD solution for treatment of certain types of seizures. We aimed to assess the safety and preliminary anti-tumor activity of Epidiolex in patients with biochemically recurrent (BCR) PCa. Experimental design: This was an open-label, single center, phase I dose escalation study followed by a dose expansion in BCR patients after primary definitive local therapy (prostatectomy +/− salvage radiotherapy or primary definitive radiotherapy). Eligible patients were screened for urine tetrahydrocannabinol prior to enrollment. The starting dose level of Epidiolex was 600 mg by mouth once daily and escalated to 800 mg daily with the use of a Bayesian optimal interval design. All patients were treated for 90 days followed by a 10-day taper. The primary endpoints were safety and tolerability. Changes in PSA, testosterone levels, and patient-reported health-related quality of life were studied as secondary endpoints. Results: Seven patients were enrolled into the dose escalation cohort. There were no dose-limiting toxicities at the first two dose levels (600 mg and 800 mg). An additional 14 patients were enrolled at the 800 mg dose level into the dose expansion cohort. The most common adverse events were 55% diarrhea (grade 1–2), 25% nausea (grade 1–2), and 20% fatigue (grade 1–2). The mean PSA at baseline was 2.9 ng/mL. At the 12-week landmark time-point, 16 out of 18 (88%) had stable biochemical disease, one (5%) had partial biochemical response with the greatest measurable decline being 41%, and one (5%) had PSA progression. No statistically significant changes were observed in patient-reported outcomes (PROs), but PROs changed in the direction of supporting the tolerability of Epidiolex (e.g., emotional functioning improved). Conclusion: Epidiolex at a dose of 800 mg daily appears to be safe and tolerable in patients with BCR prostate cancer supporting a safe dose for future studies. Full article
(This article belongs to the Section Clinical Research of Cancer)
Show Figures

Figure 1

12 pages, 443 KiB  
Review
The Impact of Fatigue on Performance and Biomechanical Variables—A Narrative Review with Prospective Methodology
by Michele Aquino, John Petrizzo, Robert M. Otto and John Wygand
Biomechanics 2022, 2(4), 513-524; https://doi.org/10.3390/biomechanics2040040 - 1 Oct 2022
Cited by 16 | Viewed by 13703
Abstract
Landing kinetics and kinematics have historically been correlated with potential injury. A factor that requires more attention associated with its correlation to injury risk includes the impact of physiological fatigue. Fatigue is a multifaceted phenomenon involving central and peripheral factors resulting in a [...] Read more.
Landing kinetics and kinematics have historically been correlated with potential injury. A factor that requires more attention associated with its correlation to injury risk includes the impact of physiological fatigue. Fatigue is a multifaceted phenomenon involving central and peripheral factors resulting in a slowing or cessation of motor unit firing and a decrease in maximal force and power. Sports participation rarely results in momentary muscular failure occurring, as many sports consist of intermittent periods of activity that are interspersed with short rest periods that allow for recovery to take place. However, over the course of the competition, fatigue can still accumulate and can result in impaired performance. Current literature on the topic struggles to replicate the peripheral and central metabolic stresses required to induce a state of fatigue that would be equivalent to athletic exposure. Furthermore, the current literature fails to demonstrate consistency regarding the kinetic implications associated with fatigue, which may be secondary to the inconsistencies associated with fatigue protocols utilized. This article focuses on providing an overview of the current literature associated with fatigue’s impact on the kinetics associated with landing from a jump. The article will provide a prospective methodology utilizing repeat bouts of the Wingate Anaerobic Power Test. The proposed protocol may help further our understanding of the relationship between fatigue and lower extremity biomechanics. Full article
(This article belongs to the Topic Human Movement Analysis)
Show Figures

Figure 1

15 pages, 1202 KiB  
Review
Oxygen Transport during Ex Situ Machine Perfusion of Donor Livers Using Red Blood Cells or Artificial Oxygen Carriers
by Silke B. Bodewes, Otto B. van Leeuwen, Adam M. Thorne, Bianca Lascaris, Rinse Ubbink, Ton Lisman, Diethard Monbaliu, Vincent E. De Meijer, Maarten W. N. Nijsten and Robert J. Porte
Int. J. Mol. Sci. 2021, 22(1), 235; https://doi.org/10.3390/ijms22010235 - 28 Dec 2020
Cited by 40 | Viewed by 5914
Abstract
Oxygenated ex situ machine perfusion of donor livers is an alternative for static cold preservation that can be performed at temperatures from 0 °C to 37 °C. Organ metabolism depends on oxygen to produce adenosine triphosphate and temperatures below 37 °C reduce the [...] Read more.
Oxygenated ex situ machine perfusion of donor livers is an alternative for static cold preservation that can be performed at temperatures from 0 °C to 37 °C. Organ metabolism depends on oxygen to produce adenosine triphosphate and temperatures below 37 °C reduce the metabolic rate and oxygen requirements. The transport and delivery of oxygen in machine perfusion are key determinants in preserving organ viability and cellular function. Oxygen delivery is more challenging than carbon dioxide removal, and oxygenation of the perfusion fluid is temperature dependent. The maximal oxygen content of water-based solutions is inversely related to the temperature, while cellular oxygen demand correlates positively with temperature. Machine perfusion above 20 °C will therefore require an oxygen carrier to enable sufficient oxygen delivery to the liver. Human red blood cells are the most physiological oxygen carriers. Alternative artificial oxygen transporters are hemoglobin-based oxygen carriers, perfluorocarbons, and an extracellular oxygen carrier derived from a marine invertebrate. We describe the principles of oxygen transport, delivery, and consumption in machine perfusion for donor livers using different oxygen carrier-based perfusion solutions and we discuss the properties, advantages, and disadvantages of these carriers and their use. Full article
(This article belongs to the Special Issue Protective Strategies against Organ Ischemic Injury)
Show Figures

Figure 1

Back to TopTop